These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities. Simoni-Wastila L, Blanchette CM, Qian J, Yang HW, Zhao L, Zuckerman IH, Pak GH, Silver H, Dalal AA. Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302 [Abstract] [Full Text] [Related]
3. An integrated care facilitation model improves quality of life and reduces use of hospital resources by patients with chronic obstructive pulmonary disease and chronic heart failure. Bird S, Noronha M, Sinnott H. Aust J Prim Health; 2010 Oct; 16(4):326-33. PubMed ID: 21138701 [Abstract] [Full Text] [Related]
4. [Costs of exacerbations of chronic obstructive pulmonary disease in primary and secondary care in 2007--results of multicenter Polish study]. Jahnz-Rózyk K, Targowski T, From S. Pol Merkur Lekarski; 2009 Mar; 26(153):208-14. PubMed ID: 19388534 [Abstract] [Full Text] [Related]
5. Cost analysis of chronic obstructive pulmonary disease in a tertiary care setting in Taiwan. Chiang CH. Respirology; 2008 Sep; 13(5):689-94. PubMed ID: 18513247 [Abstract] [Full Text] [Related]
6. [Retrospective analysis of direct costs of hospital treatment of chronic obstructive pulmonary disease exacerbations]. Jahnz-Rózyk K, Targowski T, From S, Płusa T. Pol Merkur Lekarski; 2004 May; 16 Suppl 1():91-4. PubMed ID: 15524028 [Abstract] [Full Text] [Related]
7. Assessing the costs of chronic obstructive pulmonary disease: the state medicaid perspective. Marton JP, Boulanger L, Friedman M, Dixon D, Wilson J, Menzin J. Respir Med; 2006 Jun; 100(6):996-1005. PubMed ID: 16288858 [Abstract] [Full Text] [Related]
8. Epidemiology and global impact of chronic obstructive pulmonary disease. Mannino DM. Semin Respir Crit Care Med; 2005 Apr; 26(2):204-10. PubMed ID: 16088437 [Abstract] [Full Text] [Related]
9. Predictors of hospital admission for chronic obstructive pulmonary disease exacerbations in Canadian emergency departments. Rowe BH, Villa-Roel C, Guttman A, Ross S, Mackey D, Sivilotti ML, Worster A, Stiell IG, Willis V, Borgundvaag B. Acad Emerg Med; 2009 Apr; 16(4):316-24. PubMed ID: 19298621 [Abstract] [Full Text] [Related]
14. Predicting the costs of managing patients with chronic obstructive pulmonary disease. Mapel DW, McMillan GP, Frost FJ, Hurley JS, Picchi MA, Lydick E, Spencer MD. Respir Med; 2005 Oct 28; 99(10):1325-33. PubMed ID: 16140232 [Abstract] [Full Text] [Related]
15. Can a chronic disease management pulmonary rehabilitation program for COPD reduce acute rural hospital utilization? Rasekaba TM, Williams E, Hsu-Hage B. Chron Respir Dis; 2009 Oct 28; 6(3):157-63. PubMed ID: 19643830 [Abstract] [Full Text] [Related]
17. Home-based palliative care study: site of death, and costs of medical care for patients with congestive heart failure, chronic obstructive pulmonary disease, and cancer. Enguidanos SM, Cherin D, Brumley R. J Soc Work End Life Palliat Care; 2005 Oct 28; 1(3):37-56. PubMed ID: 17387068 [Abstract] [Full Text] [Related]
18. A chronic disease management programme can reduce days in hospital for patients with chronic obstructive pulmonary disease. Rea H, McAuley S, Stewart A, Lamont C, Roseman P, Didsbury P. Intern Med J; 2004 Nov 28; 34(11):608-14. PubMed ID: 15546454 [Abstract] [Full Text] [Related]
19. Does admission from different sources have any influence on intensive care unit outcome in COPD patients? Aydoğdu M, Gürsel G. Tuberk Toraks; 2008 Nov 28; 56(4):375-81. PubMed ID: 19123072 [Abstract] [Full Text] [Related]